Carcinogenicity test of six nitrosamides and a nitrosocyanamide administered orally to rats. 1979

O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen

Six nitrosamides [ethylnitrosourea (ENU), 2-hydroxyethylnitrosourea (HENU), carboxymethylnitrosourea, 1-nitroso-5,6-dihydrouracil (NDHU), 1-nitrosohydantoin, and N-methyl-N-nitrosobenzamide (MNB)] and ethylnitrosocyanamide (ENC) were administered chronically in sodium citrate-buffered drinking water to MRC Wistar rats. ENU induced tumors of the reticuloendothelial system (RES) (50% incidence), mammary glands, and large intestine. NDHU in drinking water produced hepatocellular carcinomas (96% incidence), but NDHU injected ip caused mostly tumors at the injection sites (54% incidence). HENU produced bone tumors (38% incidence) and RES tumors (28% incidence). ENC produced nasal cavity tumors (36% incidence). Papillomas and/or carcinomas of the forestomach, tongue, and pharynx were induced by most of the compounds, with the highest incidence in the forestomach (47% for MNB); these tumors were attributed to local action when the compounds were ingested. Carcinogenicity was not quantitatively correlated with direct mutagenicity for Salmonella typhimurium TA1535.

UI MeSH Term Description Entries
D008297 Male Males
D009153 Mutagens Chemical agents that increase the rate of genetic mutation by interfering with the function of nucleic acids. A clastogen is a specific mutagen that causes breaks in chromosomes. Clastogen,Clastogens,Genotoxin,Genotoxins,Mutagen
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D009602 Nitrosamines A class of compounds that contain a -NH2 and a -NO radical. Many members of this group have carcinogenic and mutagenic properties. Nitrosamine
D009603 Nitroso Compounds Organic compounds containing the nitroso (-N Compounds, Nitroso
D009607 Nitrosourea Compounds A class of compounds in which the core molecule is R-NO, where R is UREA. Compounds, Nitrosourea
D012142 Respiratory Tract Neoplasms Tumors or cancer of the RESPIRATORY SYSTEM. Respiratory Neoplasms,Respiratory System Neoplasms,Neoplasm, Respiratory,Neoplasm, Respiratory System,Neoplasm, Respiratory Tract,Respiratory Neoplasm,Respiratory System Neoplasm,Respiratory Tract Neoplasm
D012157 Mononuclear Phagocyte System Mononuclear cells with pronounced phagocytic ability that are distributed extensively in lymphoid and other organs. It includes MACROPHAGES and their precursors; PHAGOCYTES; KUPFFER CELLS; HISTIOCYTES; DENDRITIC CELLS; LANGERHANS CELLS; and MICROGLIA. The term mononuclear phagocyte system has replaced the former reticuloendothelial system, which also included less active phagocytic cells such as fibroblasts and endothelial cells. (From Illustrated Dictionary of Immunology, 2d ed.) Reticuloendothelial System,Phagocyte System, Mononuclear,System, Mononuclear Phagocyte,System, Reticuloendothelial
D002273 Carcinogens Substances that increase the risk of NEOPLASMS in humans or animals. Both genotoxic chemicals, which affect DNA directly, and nongenotoxic chemicals, which induce neoplasms by other mechanism, are included. Carcinogen,Oncogen,Oncogens,Tumor Initiator,Tumor Initiators,Tumor Promoter,Tumor Promoters,Initiator, Tumor,Initiators, Tumor,Promoter, Tumor,Promoters, Tumor
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug

Related Publications

O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
November 1983, Journal of the National Cancer Institute,
O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
April 1982, Journal of the American Academy of Dermatology,
O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
September 1963, Food and cosmetics toxicology,
O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
November 1970, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
May 1984, Cancer letters,
O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
November 2001, Chemical & pharmaceutical bulletin,
O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
March 2016, Journal of agricultural and food chemistry,
O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
December 2003, Chemical & pharmaceutical bulletin,
O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
May 2006, Journal of natural products,
O Bulay, and S S Mirvish, and H Garcia, and A F Pelfrene, and B Gold, and M Eagen
August 1988, Fundamental and applied toxicology : official journal of the Society of Toxicology,
Copied contents to your clipboard!